Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
HCC1937 | AZD7762 | CHK1/2 | Cell cycle | 0.166 | -0.3625 | 0.4881 | 0.1939 | 1.0122 | 0.26931 | 0.9768 |
HCC1937 | Volasertib | PLK | Cell cycle | 0.011931 | -0.1480 | 0.4968 | 0.1111 | 1.6595 | 0.013417 | 0.99404 |
HCC1937 | Dinaciclib | pan CDK | Cell cycle | 0.021814 | -0.2071 | 0.4822 | 0.0817 | 5.0000 | 0.02333 | 0.9981 |
HCC1937 | Cisplatin | Chemo | Chemotherapy | 0.7769 | 0.0060 | 0.3266 | 0.0782 | 0.6212 | 1.7561 | 0.98656 |
HCC1937 | Doxorubicin | Chemo | Chemotherapy | 0.012819 | -0.1660 | 0.5790 | 0.1786 | 1.3570 | 0.012547 | 0.9584 |
HCC1937 | Taxol | Chemo | Chemotherapy | 0.0024514 | 0.0104 | 0.6576 | 0.2104 | 2.2541 | 0.0024561 | 0.99541 |
HCC1937 | Topotecan | Topo I | Chemotherapy | 0.0155 | -0.4282 | 0.8369 | 0.2949 | 0.6712 | 0.03544 | 0.94323 |
HCC1937 | Etoposide | Topo II | Chemotherapy | 0.35445 | -0.1182 | 0.3932 | 0.1412 | 0.8265 | 0.49943 | 0.98817 |
HCC1937 | Dasatinib | BCR/ABL | MAPK/nRTK | 0.11264 | 0.0153 | 0.4415 | 0.1071 | 1.7303 | 0.097801 | 0.98944 |
HCC1937 | Trametinib | MEK | MAPK/nRTK | Inf | 0.6885 | 0.1384 | 0.0485 | 1.0415 | 0.012758 | 0.98277 |
HCC1937 | Saracatinib | SRC | MAPK/nRTK | Inf | 0.6508 | 0.0392 | 0.0248 | 1.9114 | 3.8679 | 0.97821 |
HCC1937 | ABT-737 | Bcl2/XL | Misc | 5.7613 | 0.2685 | 0.0849 | 0.0618 | 1.0314 | 14.9529 | 0.9843 |
HCC1937 | Vorinostat | HDAC | Misc | 1.9099 | -0.0085 | 0.1933 | 0.0353 | 1.4929 | 2.1786 | 0.99505 |
HCC1937 | Luminespib | HSP90 | Misc | 0.011448 | -0.1867 | 0.5478 | 0.2244 | 4.8554 | 0.012181 | 0.99929 |
HCC1937 | A-1210477 | Mcl-1 | Misc | Inf | 0.7240 | 0.0060 | 0.0046 | 4.0529 | 5.9209 | 0.95858 |
HCC1937 | Olaparib | PARP | Misc | 26.5474 | 0.6855 | 0.0584 | 0.0092 | 0.6339 | 150.1948 | 0.9681 |
HCC1937 | Bleomycin | Radiation | Misc | 0.1866 | 0.1388 | 0.4157 | 0.1325 | 0.9803 | 0.14295 | 0.99691 |
HCC1937 | Ipatasertib | AKT | PI3K/mTOR | Inf | 0.5349 | 0.1565 | 0.0058 | 1.0014 | 0.36202 | 0.97156 |
HCC1937 | Alpelisib | PI3Ka | PI3K/mTOR | 18.8171 | 0.6577 | 0.0501 | 0.0085 | 0.8078 | 73.2808 | 0.94623 |
HCC1937 | Taselisib | PI3Ka, g, d | PI3K/mTOR | 1.2267 | 0.1206 | 0.2771 | 0.0422 | 0.5159 | 3.7186 | 0.99159 |
HCC1937 | TGX221 | PI3Kb | PI3K/mTOR | Inf | 0.8377 | 0.0202 | 0.0070 | 0.6226 | 52.0493 | 0.74303 |
HCC1937 | Torin2 | mTOR/ATM/ATR | PI3K/mTOR | 0.093408 | 0.0726 | 0.2910 | 0.0569 | 0.5617 | 0.18674 | 0.97982 |
HCC1937 | Everolimus | mTOR1 | PI3K/mTOR | Inf | 0.6324 | 0.3348 | 0.0206 | 0.4211 | 0.00012787 | 0.92563 |
HCC1937 | INK-128 | mTORC1/2 | PI3K/mTOR | 0.051498 | 0.3579 | 0.3694 | 0.0196 | 1.0019 | 0.011127 | 0.99251 |
HCC1937 | PF-4708671 | p70S6K | PI3K/mTOR | Inf | 0.7688 | 0.0390 | 0.0001 | 0.6190 | 21.7234 | 0.88762 |